Global Long-acting Recombinant Human Erythropoietin Injections Supply, Demand and Key Producers, 2023-2029

Global Long-acting Recombinant Human Erythropoietin Injections Supply, Demand and Key Producers, 2023-2029

The global Long-acting Recombinant Human Erythropoietin Injections market size is expected to reach $ 1234.2 million by 2029, rising at a market growth of 5.2% CAGR during the forecast period (2023-2029).

The market for long-acting recombinant human erythropoietin injections is a vital biopharmaceutical product used primarily in the treatment of anemia, particularly associated with kidney disease and anemia resulting from chemotherapy in leukemia. The market is substantial and continues to grow, benefitting from the ongoing expansion of global healthcare systems and the persistent demand for anemia treatments. In the future, with the continued advancement of biotechnology and increasing therapeutic needs, long-acting recombinant human erythropoietin injections are poised for further development, potentially involving broader application areas and improved therapeutic solutions to offer more effective anemia management for patients.

Long-acting erythropoietin (EPO) drugs are a type of medication used to stimulate the production of red blood cells in the body. These drugs are primarily prescribed for individuals with certain medical conditions, such as anemia associated with chronic kidney disease or cancer treatment.

This report studies the global Long-acting Recombinant Human Erythropoietin Injections production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-acting Recombinant Human Erythropoietin Injections, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Recombinant Human Erythropoietin Injections that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Long-acting Recombinant Human Erythropoietin Injections total production and demand, 2018-2029, (K Units)

Global Long-acting Recombinant Human Erythropoietin Injections total production value, 2018-2029, (USD Million)

Global Long-acting Recombinant Human Erythropoietin Injections production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Injections consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Long-acting Recombinant Human Erythropoietin Injections domestic production, consumption, key domestic manufacturers and share

Global Long-acting Recombinant Human Erythropoietin Injections production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Injections production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Long-acting Recombinant Human Erythropoietin Injections production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Long-acting Recombinant Human Erythropoietin Injections market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson and Kyowa Kirin, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Recombinant Human Erythropoietin Injections market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-acting Recombinant Human Erythropoietin Injections Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Long-acting Recombinant Human Erythropoietin Injections Market, Segmentation by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Global Long-acting Recombinant Human Erythropoietin Injections Market, Segmentation by Application
Anemia
Kidney Disorders
Others

Companies Profiled:
Amgen
Johnson & Johnson
Kyowa Kirin

Key Questions Answered

1. How big is the global Long-acting Recombinant Human Erythropoietin Injections market?

2. What is the demand of the global Long-acting Recombinant Human Erythropoietin Injections market?

3. What is the year over year growth of the global Long-acting Recombinant Human Erythropoietin Injections market?

4. What is the production and production value of the global Long-acting Recombinant Human Erythropoietin Injections market?

5. Who are the key producers in the global Long-acting Recombinant Human Erythropoietin Injections market?